Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Work In Process (2011 - 2012)

Updated

Vertex Pharmaceuticals (VRTX) recorded Work In Process of $58.45 million in Q3 2012, up 64.4% from $35.54 million a year earlier but down 1.3% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Work In Process (2011 - 2012) Analysis & Trends

At the end of FY2011, Vertex Pharmaceuticals reported Work In Process of $47.01 million.

  • Quarterly Work In Process has ranged from $10 million in Q1 2011 to $74.74 million in Q1 2012 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $59.22 million (Q2 2012), $74.74 million (Q1 2012) and $47.01 million (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 58.45 Mn
Jun 30, 2012 59.22 Mn
Mar 31, 2012 74.74 Mn
Dec 31, 2011 47.01 Mn
Sep 30, 2011 35.54 Mn
Jun 30, 2011 29.27 Mn
Mar 31, 2011 10.00 Mn
API Access

Vertex Pharmaceuticals Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=VRTX&period=max&api_key=YOUR_API_KEY